Article ID Journal Published Year Pages File Type
5702534 Urologic Oncology: Seminars and Original Investigations 2017 9 Pages PDF
Abstract
Patients receiving EBRT for low-risk prostate cancer suffer declines in bowel HRQoL. These declines are not experienced by patients on AS, suggesting that management of low-risk prostate cancer with AS may offer a means for preserving HRQoL following prostate cancer diagnosis.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , , ,